The CCNC embraces a clinical translational science approach towards understanding risk factors and "illness" mechanisms of schizophrenia and related psychological disorders (e.g., bipolar disorder, schizotypal personality disorder, autism spectrum disorder) using both human and animal models. Over the years, the lab has pursued research in understanding the basic neural contributions to psychosis-spectrum disorders including among other things (1) cerebellar structural and functional contributions to cognitive processes, (2) brain-behavior relationships that underlie temporal, perceptual, and attentional anomalies, (3) the role of neural synchrony and oscillations in normal and perturbed brain function, and (4) uncovering cognitive and behavioral disturbances characteristic to schizophrenia-spectrum and bipolar disorders. Moreover, the lab has been invested in the evaluation of both behavioral and pharmacological treatments of schizophrenia through clinical trials.
For more on current lab studies and the methods used, see our Research page.